Effect of Omalizumab Therapy on Coagulation Parameters and Total Immunoglobulin E Levels in Patients with Chronic Idiopathic Urticaria and Bullous Pemphigoid

---

Copy For Citation

İncel Uysal P., Hayran Y., AKDOĞAN N., ÖKTEM A., Uğur Atılan A., GÜR AKSOY G., ...More

TURK DERMATOLOJI DERGISI, vol.12, pp.159-166, 2018 (ESCI)

• Publication Type: Article / Article
• Volume: 12
• Publication Date: 2018
• Doi Number: 10.4274/tdd.3668
• Journal Name: TURK DERMATOLOJI DERGISI
• Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
• Page Numbers: pp.159-166
• Keywords: Anti-immunoglobulin E therapy, bullous pemphigoid, chronic urticaria, coagulation parameters, immunoglobulin E, omalizumab, DIMER PLASMA-LEVELS, BLOOD-COAGULATION, CLINICAL-RESPONSE, IGE, INFLAMMATION, AUTOIMMUNITY, ACTIVATION, DISEASE, MARKERS
• Ankara University Affiliated: Yes

Abstract

Objective: The aim of this study is to assess the impact of omalizumab on coagulation biomarkers and immunoglobulin E (IgE) levels in chronic idiopathic urticaria/chronic spontaneous urticaria (CIU/CSU) and bullous pemphigoid (BP) patients.